drugset / Trial / NCT07587164
C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in Indonesia
Completed
300 enrolled
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Respiratory Programmatic Implementation and Research Institute (RPRI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is an operational research in household/close contacts of confirmed TB patients to evaluate the effectiveness of C-TST compared to IGRA test in identifying latent TB cases using parameters of effectiveness and safety.
Timeline
- Start
- 2025-05-26
- Primary completion
- 2025-08-21
- Completion
- 2025-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Mycobacterium Tuberculosis Fusion Protein Tuberculin Skin Test | Diagnostic / imaging agent | 0.1 ml | Other |
| Subject | Recombinant Mycobacterium Tuberculosis Fusion Protein Tuberculin Skin Test | Diagnostic / imaging agent | 5 iu | Other |